Harpoon Therapeutics, Inc.

NASDAQ:HARP

23.01 (USD) • At close March 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Operating Activities:
Net Income -1.8021.061-11.338-18.419-11.64-17.351-20.321-21.552-16.682-16.763-61.724-11.357-13.307-12.692-12.552-14.268-15.908-11.817-13.579-9.731-6.76-5.994-4.881-4.94
Depreciation & Amortization 0.2360.370.6620.6780.5270.5480.6040.5580.5340.5490.5490.5370.530.5120.5030.5-0.1960.2990.2970.1970.1590.1490.1390.122
Deferred Income Tax -0.182.254000000.5150.6860.5940.5740.2360.1250.070.06-0.059-0.261-0.176-0.0451.0750.001000
Stock Based Compensation 0.9181.0641.1341.4931.7792.5212.8432.6492.342.3372.1361.3311.5041.1780.8470.6430.5920.4670.3690.2110.1740.140.1470.14
Change In Working Capital -6.686-23.018-10.208-2.355-14.763-7.631-8.8290.845-7.7-53.41840.363-6.034-2.44948.383-6.47346.814.188-2.1940.2452.879-0.675-0.734-2.54617.32
Accounts Receivables 00000000000000000000.500-0.50
Change In Inventory 00000000000000000000.80600-0.480
Change In Accounts Payables 0.368-0.666-0.712.1-0.178-0.8210.9460.571-0.455-0.6441.07-0.4130.2170.058-1.09-1.0640.179-0.105-0.7712.5650.0220.477-0.5090.816
Other Working Capital -7.054-22.352-9.498-4.455-14.585-6.81-9.7750.274-7.245-52.77439.293-5.621-2.66648.325-5.38347.8744.009-2.0891.016-0.992-0.697-1.211-1.05716.504
Other Non Cash Items -9.0153.0930.4640.2130.1460.310.4650.1520.1440.1350.0250.120.110.1040.0980.0920.3480.4740.288-1.075-0.00100-0.001
Operating Cash Flow -16.529-15.176-19.286-18.39-23.951-21.603-25.238-16.833-20.678-66.566-18.077-15.167-13.48737.555-17.51733.718-11.237-12.947-12.425-6.444-7.102-6.439-7.14112.641
Investing Activities:
Investments In Property Plant And Equipment -0.09100-0.028-0.266-0.0530.597-0.05500-0.045-0.058-0.47-0.15-0.005-0.369-1.754-1.321-0.072-0.157-0.191-0.223-0.092-0.022
Acquisitions Net 00.3410.938000-0.597000000000.83500000000
Purchases Of Investments -2.938-12.7140-11.509-12.917-1.004-10.505-17.396-34.1-17.513-82.956-60.096-35.518-60.065-46.503-52.949-6.573-30.717-51.57700000
Sales Maturities Of Investments 201.514.27518.83341.03540.36736.13719.97887.20343.10170.59936.31921.12911.19251.04724.1350000000
Other Investing Activites 00011.5090-0.5970.59700000000-0.83500.835000000
Investing Cash Flow -1.029-12.3732.43814.2475.6539.38130.45918.686-14.12269.69-39.910.4450.331-39.086-35.316-2.27115.808-31.203-51.649-0.157-0.191-0.223-0.092-0.022
Financing Activities:
Debt Repayment 000000000000000000000000
Common Stock Issued 2.2430.2621.5265.3820.10100.830.00102.767107.5813.032000-0.001-0.0170.19170.47389.8280000
Common Stock Repurchased 748.57600000000000000000000000
Dividends Paid 000000000000000000000000
Other Financing Activities -748.787-1.30125.0930.00700.05200.0460.380.1870.5610.2091.0690.1010.2650.5260.1160.1270.034-21.59220.0580.0220.010.002
Financing Cash Flow 2.032-1.03926.6195.3890.1010.0520.830.0470.382.954108.1423.2411.0690.1010.2650.5250.0990.31870.50768.23620.0580.0220.010.002
Other Information:
Effect Of Forex Changes On Cash 1,481.90400000000000000000000000
Net Change In Cash -15.526-28.5889.7711.246-18.217.836.0511.9-34.426.07850.165-1.481-12.087-1.43-52.56831.9724.67-43.8326.43361.63512.765-6.64-7.22312.621
Cash At End Of Period 17.94433.4762.05852.28751.04169.24151.41145.3643.4677.8871.80221.63723.11835.20536.63589.20357.23152.56196.39389.9628.32515.5622.229.423